bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.03.27.645854

IP3R2 mediated inter-organelle Ca2+ signaling orchestrates melanophagy

Abstract

Organelle dynamics and crosstalk play a critical role in cellular functions thereby regulating physiological processes and pathological conditions. A variety of cellular processes are outcome of a balance between organelle biogenesis and degradation. Pigmentation is one such homeostatic state that is a result of melanosome biogenesis and melanosome degradation. Although melanosome biogenesis is partially understood, the melanosome degradation i.e. melanophagy remains largely unappreciated. Here, we reveal that Inositol 1,4,5-trisphosphate receptor 2 (IP3R2) is a negative regulator of melanophagy. In this study, we developed two de novo ratio metric imaging probes to study melanophagy in live-cells. Using these probes, biochemical assays, ultrastructural studies, confocal microscopy, molecular analyses and calcium imaging; we demonstrate that IP3R2, but not IP3R1 or IP3R3, keeps melanophagy in check. In vivo studies in zebrafish model system further substantiate IP3R2s functional relevance in pigmentation. Mechanistically, IP3R2 silencing decreases mitochondrial Ca2+ uptake, augments ADP/ATP ratio and thereby activates melanophagy. Simultaneously, IP3R2 knockdown increases ER-lysosome proximity, enhances lysosomal Ca2+ levels and decreases lysosomal pH. This in turn activates lysosomal TRPML1 channel and stimulates nuclear translocation of TFEB transcription factor, which facilitates transcription of key autophagy and two known melanophagy drivers. Taken together, we uncover that IP3R2-mediated Ca2+ signaling across organelles is a critical determinant of melanophagy and thereby skin pigmentation. Hence, this signaling cascade offers potential therapeutic prospects for the management of pigmentary disorders and skin malignancies. Highlights[tpltrtarr] IP3R2, but not IP3R1 and IP3R3, is a critical positive regulator of melanogenesis in vitro and in vivo. [tpltrtarr]Generation and validation of two de novo ratio-metric live cells imaging probes reveal crucial role of IP3R2 in melanophagy. [tpltrtarr]IP3R2 knockdown decreases mitochondrial Ca2+ uptake, augments ADP/ATP ratio and thereby activates melanophagy via AMPK-ULK1 pathway. [tpltrtarr]IP3R2 silencing enhances ER-lysosomal proximity, elevates lysosomal Ca2+ levels and reduces lysosomal pH. [tpltrtarr]IP3R2 knockdown stimulates lysosomal TRPML1 channel activity thereby facilitating nuclear translocation of TFEB transcription factor. [tpltrtarr]TFEB transcriptionally upregulates genes involved in the melanophagy process, leading to enhanced degradation of melanosomes and decreased pigmentation.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Saurav, S., Motiani, R. K.. 2025-03-28. IP3R2 mediated inter-organelle Ca2+ signaling orchestrates melanophagy. https://doi.org/10.1101/2025.03.27.645854

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

High-content screening identifies FDA-approved activators of mitophagy

Mitochondrial diseases are highly heterogeneous disorders caused by defects in oxidative phosphorylation, for which only limited therapeutic options are available. The elimination of dysfunctional mitochondria via mitophagy activation is an attractive strategy to treat several mitochondrial diseases, irrespective of the underlying genetic defect. To identify pharmacological activators of this pathway, we performed a high-content screening of 1,971 FDA-approved compounds using cellular reporters of TFEB nuclear translocation and mitophagy. This screening identified 294 compounds that promoted TFEB translocation, nine of which increased the number of mitolysosomes without compromising cell viability or damaging mitochondria. Among the selected compounds, Meptazinol and Ponatinib emerged as the top-ranked mitophagy inducers in fibroblasts from patients with complex I and IV deficiency, respectively, and were prioritised for further characterisation. However, they did not rescue the bioenergetic defect, suggesting that the stimulation of mitophagy per se is not sufficient to ameliorate the OXPHOS defect in mitochondrial diseases. Overall, our findings establish a scalable platform for the identification of pharmacological activators of TFEB and identify candidate compounds for therapeutic modulation of mitophagy.

cell biology↗

A LOV-domain photoreceptor mediates phototaxis in brown algae

Phototaxis enables motile cells to navigate light environments and plays a critical role in survival and reproduction across diverse eukaryotic lineages. This ability has evolved independently through distinct photoreceptor systems. Yet, the molecular mechanisms underlying phototaxis remain poorly understood in many major eukaryotic lineages, including stramenopiles. Here, combining functional genetics, cell biology and evolutionary analyses, we identify Helmchrome (HELM), a LOV-domain protein required for phototaxis in the brown alga Ectocarpus. HELM localizes to the posterior flagellum and is responsible for the characteristic flavin-associated fluorescence of brown algal gametes. Loss of HELM abolishes phototactic accumulation and directional orientation without affecting basal motility or fertilization, demonstrating its specific requirement for light-directed movement. Phylogenetic analyses reveal that HELM-like proteins are distributed across diverse stramenopile lineages and that their domain architecture evolved through repeated duplication of an ancestral RGS-LOV module. Our findings identify HELM as a key component of the light-sensing machinery in brown algae, provide a molecular explanation for the long-standing observation of flagellar flavin fluorescence, and reveal a distinct phototaxis system that expands the known diversity of eukaryotic light-sensing mechanisms.

cell biology↗

A distinct chondrogenic progenitor population from human umbilical cord derived mesenchymal stromal cells for osteoarthritis therapy

Stem cell-based cartilage regeneration remains constrained by functional heterogeneity and phenotypic drift in conventional cell sources, compromising durable structural repair. Human umbilical cord-derived mesenchymal stromal cells (UC-MSCs) represent an accessible, off-the-shelf cell source; however, their broad clinical utility is hampered by cellular heterogeneity, leaving the key chondrogenic subpopulation responsible for cartilage repair unresolved. By integrating single-cell transcriptomics with functional assays, we identified and prospectively isolated a distinct, highly expandable subpopulation of skeletal stem cell-like progenitors (U-CPCs) from the human umbilical cord, establishing an extra-skeletal cell source uniquely primed for joint restoration. Single-cell transcriptomics reveal their inherent regulatory landscape, uncovering a distinct transcriptional state uniquely primed for chondrogenesis. In comparison with conventional stem cells and other tissue-derived SSC-like populations (from umbilical cord, bone marrow, adipose tissue, and dental pulp), U-CPCs exhibit a markedly enhanced chondrogenic capacity. In both a mouse cartilage injury model and a rat osteoarthritis model, the administration of U-CPCs effectively mitigates joint degeneration and drives the restoration of a structurally sound, hyaline-like matrix. Mechanistically, U-CPCs secrete extracellular vesicles enriched with microRNA Let-7a-5p, which specifically modulates DUSP7/MAPK/ERK signaling in recipient chondrocytes, thereby restoring extracellular matrix homeostasis and promoting cartilage repair. By characterizing these specialized extra-skeletal progenitors and elucidating both their intrinsic chondrogenic priming and paracrine regulation of host tissue, this study establishes U-CPCs as a robust, lineage-restricted cellular source for osteoarthritis therapy.

cell biology↗